<unk> , sold under the brand names Jublia and Clenafin, is a triazole antifungal. It is approved for use in the United States, Canada, and Japan as a 10% topical solution for the treatment of onychomycosis (fungal infection of the nail).<unk>  acts as a 14α-demethylase inhibitor. It was approved as a generic medication in the United States in 2020.
Efinaconazole
Itraconazole
Sertaconazole
Miconazole
Posaconazole
Ketoconazole
Levoketoconazole
Terbinafine